Hjem › Alzheimers sykdom › Georgia
Kliniske studier for Alzheimers sykdom i Georgia
24 studier for Alzheimers sykdom søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Augusta
- Clinical Site, Snellville
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- CenExeli Research LLC, Savannah
RekruttererFase 2
Alder 55 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2611, Atlanta
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Accel Research - NeuroStudies, Decatur
RekruttererFase 4
Alder 50 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07633470A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Local Institution - 0004, Decatur
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 80 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07780383A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Agile Clinical Research Trials, LLC, Atlanta
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Columbus Memory Center, Columbus
- Center for Advanced Research & Education Flourish-Gainesville, Gainsville
RekruttererFase 2
Alder 55 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Grady Memorial Hospital, Atlanta
- Alzheimer's Research and Treatment Center - Columbus, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- og 2 flere
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Agile Clinical Research Trials, LLC, Atlanta
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- CenExel iResearch, LLC, Decatur
- CenExel iResearch, LLC, Savannah
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- CenExel iResearch, LLC ( Site 1015), Decatur
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel iResearch, LLC (CenExel iRA), Decatur
RekruttererFase 1
Alder 50 til 85 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06297590AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Alzheimer's Research and Treatment Center (Columbus), Columbus
RekruttererFase 1
Alder 65 til 80 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07158905A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Center for Advanced Research & Education, Gainesville
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Emory University School of Medicine, Atlanta
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05552157A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT06647498Moving Yourself in Space and Time: MYSTIC
- Emory University, Executive Park, Wesley Woods, Atlanta
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 79 · Alle kjønn · Oppdatert 13. jul. 2026 · NCT07697664A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Center for Advanced Research & Education, Gainesville
- North Georgia Clinical Research, Woodstock
RekruttererFase 3
Alder 55 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Atlanta Center of Medical Research, Atlanta
- CenExel iResearch, LLC (CenExel iRA), Decatur
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 45 til 85 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06657768Inspiring Seniors Towards Exercise Promotion to Protect Cognition
- Emory University, Atlanta
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 65 og eldre · Alle kjønn · Oppdatert 30. apr. 2026 · NCT06496425Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- Emory Rehabilitation Hospital, Atlanta
Rekrutterer
Alder 50 til 90 · Alle kjønn · Oppdatert 2. mar. 2026 · NCT06484244Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Reminiscent, Valdosta
Rekrutterer
Alder 65 til 90 · Alle kjønn · Oppdatert 4. feb. 2026 · NCT05205980A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- Wellstar MCG Hospital, Neurology Memory Clinic, Augusta
RekruttererFase 1
Alder 65 til 85 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT07218081Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.